CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Open-market sale VP & Chief Scientific Officer sold 1,935 shares at an average $6.55 ($12,669)
- 4 Open-market sale VP & Chief Scientific Officer sold 2,691 shares at an average $6.58 ($17,711)
- 4 Open-market sale Vice President and CSO sold 5,374 shares at an average $6.74 ($36,201)
- 4 Returned to the company Director returned 1,009 shares (to the company)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 955 shares at $6.67 ($6,370)
- 4 Open-market buy Director bought 9,522 shares at $5.25 ($49,991)
- 4 Open-market buy Director bought 6,666 shares at $5.25 ($34,997)
- 4 Open-market buy Director bought 2,857 shares at $5.25 ($14,999)
- 4 Open-market buy Director bought 1,904 shares at $5.25 ($9,996)
- 4 Open-market buy Director bought 24,000 shares
- 4 Open-market buy Director bought 175 shares at $6.80 ($1,190)
- 4 Open-market buy Director bought 3,000 shares at an average $6.63 ($19,881)
- 4 Open-market buy Director bought 1,000 shares at $6.73 ($6,730)
- 4 Open-market buy Director bought 1,500 shares at $7.27 ($10,905)
- 4 Open-market buy Director bought 6,100 shares at an average $7.37 ($44,968)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 2,100 shares at an average $4.82 ($10,116)
- 4 Open-market buy Director bought 400 shares at $4.80 ($1,920)
Page 6 of 13 · 256 filings